Cargando…
A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program—AIM-HY INFORM trial
BACKGROUND: Ethnicity, along with a variety of genetic and environmental factors, is thought to influence the efficacy of antihypertensive therapies. Current UK guidelines use a “black versus white” approach; in doing so, they ignore the United Kingdom's largest ethnic minority: Asians from Sou...
Autores principales: | Mukhtar, Omar, Cheriyan, Joseph, Cockcroft, John R., Collier, David, Coulson, James M., Dasgupta, Indranil, Faconti, Luca, Glover, Mark, Heagerty, Anthony M., Khong, Teck K., Lip, Gregory Y.H., Mander, Adrian P., Marchong, Mellone N., Martin, Una, McDonnell, Barry J., McEniery, Carmel M., Padmanabhan, Sandosh, Saxena, Manish, Sever, Peter J., Shiel, Julian I., Wych, Julie, Chowienczyk, Phil J., Wilkinson, Ian B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mosby
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234107/ https://www.ncbi.nlm.nih.gov/pubmed/30092411 http://dx.doi.org/10.1016/j.ahj.2018.05.006 |
Ejemplares similares
-
Sample size re-estimation in crossover trials: application to the AIM HY-INFORM study
por: Wych, Julie, et al.
Publicado: (2019) -
Skin Sodium and Hypertension: a Paradigm Shift?
por: Selvarajah, Viknesh, et al.
Publicado: (2018) -
Arterial Stiffness Can Be Modulated by Pressure‐Independent Mechanisms in Hypertension
por: Faconti, Luca, et al.
Publicado: (2019) -
Commissaris krijgt de regie
por: Kiers, Bart
Publicado: (2020) -
Primary hypertension, anti-hypertensive medications and the risk of severe COVID-19 in UK Biobank
por: Pavey, Holly, et al.
Publicado: (2022)